Header Logo

Connection

RITSUKO KOMAKI to Dacarbazine

Back to Details
This is a "connection" page, showing publications RITSUKO KOMAKI has written about Dacarbazine.
RITSUKO KOMAKI
Connection Strength
0.090
Dacarbazine
  1. A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320. Int J Radiat Oncol Biol Phys. 2013 Apr 01; 85(5):1312-8.
    View in: PubMed
    Score: 0.090
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.